EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sisram Medical's enterprise value is HK$1,685 Mil.
Sisram Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil. Therefore, Sisram Medical's EV-to-EBITDA for today is 5.50.
The historical rank and industry rank for Sisram Medical's EV-to-EBITDA or its related term are showing as below:
HKSE:01696'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.79 Med: 5.31 Max: 56.47
Current: 5.5
During the past 10 years, the highest EV-to-EBITDA of Sisram Medical was 56.47. The lowest was 0.79. And the median was 5.31.
HKSE:01696's EV-to-EBITDA is ranked better than 87.04% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 16.14
vs HKSE:01696: 5.50
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Sisram Medical EV-to-EBITDA Historical Data
The historical data trend for Sisram Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sisram Medical's EV-to-EBITDA
For the Medical Devices subindustry, Sisram Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sisram Medical's EV-to-EBITDA falls into.
Sisram Medical EV-to-EBITDA Calculation
Sisram Medical's EV-to-EBITDA for today is calculated as:
Sisram Medical's current Enterprise Value is HK$1,685 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (HKSE:01696) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sisram Medical's PE Ratio for today is calculated as:
Sisram Medical's share price for today is HK$3.94.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.527.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Sisram Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01696 has been successfully added to your 